WelleCo Australia The Clarity Elixir

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

ダウンロード 公開評価報告書 (PAR)
11-07-2022

有効成分:

Rhodiola rosea, Quantity: 85.71 mg (Equivalent: Rhodiola rosea, Qty 857.1 mg); Bacopa monnieri, Quantity: 131.58 mg (Equivalent: Bacopa monnieri, Qty 2.5 g); Panax ginseng, Quantity: 25 mg (Equivalent: Panax ginseng, Qty 250 mg); calcium pantothenate, Quantity: 10.87 mg (Equivalent: pantothenic acid, Qty 10 mg); pyridoxine hydrochloride, Quantity: 3.65 mg (Equivalent: pyridoxine, Qty 3 mg); cyanocobalamin, Quantity: 10 microgram; acetyl levocarnitine hydrochloride, Quantity: 25 mg; tyrosine, Quantity: 50 mg; zinc amino acid chelate, Quantity: 7.5 mg (Equivalent: zinc, Qty 1.5 mg)

から入手可能:

Welle Pty Ltd

医薬品形態:

Capsule, hard

構図:

Excipient Ingredients: maltodextrin; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; chlorophyllin-copper complex

投与経路:

Oral

適応症:

Maintain/support energy levels ; Maintain/support physical endurance/capacity/stamina ; Maintain/support vitality ; Relieve weariness/tiredness/fatigue/feeling of weakness ; Maintain/support general health and wellbeing ; Support healthy body stress recovery ; Support healthy stress response in the body ; Maintain/support mental concentration/focus/clarity ; Maintain/support mental endurance/stamina ; Maintain/support cognitive function/mental function ; Maintain/support learning and information processing ; Maintain/support memory/mental recall ; Maintain/support brain function ; Maintain/support brain health ; Maintain/support nervous system health ; Maintain/support nervous system function

製品概要:

Visual Identification: ;

認証ステータス:

Listed

承認日:

2022-07-06